Thermo Fisher Scientific (TMO)
(Delayed Data from NYSE)
$596.92 USD
+3.13 (0.53%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $596.52 -0.40 (-0.07%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth D Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$596.92 USD
+3.13 (0.53%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $596.52 -0.40 (-0.07%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth D Momentum D VGM
Zacks News
Thermo Fisher Scientific (TMO) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Thermo Fisher Scientific (TMO) closed the most recent trading day at $467.53, moving +0.17% from the previous trading session.
The Zacks Analyst Blog Highlights: Emergent BioSolutions, Vertex Pharmaceuticals, Editas Medicine, Cellectis and Thermo Fisher
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Emergent BioSolutions, Vertex Pharmaceuticals, Editas Medicine, Cellectis and Thermo Fisher
Abbott's New Antibody Test Gets FDA's EUA, Test Suite Expands
by Zacks Equity Research
Abbott's (ABT) latest antibody test is expected to give a clearer picture of the rate of recovery post coronavirus infection.
Here's Why You Should Add AngioDynamics to Your Portfolio Now
by Zacks Equity Research
Investor confidence is high in AngioDynamics (ANGO) stock, thanks to solid prospects.
Here's Why You Should Hold on to Stryker (SYK) Stock Now
by Zacks Equity Research
Stryker (SYK) continues to benefit from strength in its robotic-arm assisted surgery platform - Mako and broad product portfolio. However, pricing pressure raises concern.
What's in Store for Intuitive Surgical's (ISRG) Q3 Earnings?
by Zacks Equity Research
Intuitive Surgical's (ISRG) third-quarter earnings are likely to reflect weaker-than-expected performance at Instruments & Accessories segment.
Is Thermo Fisher Scientific (TMO) Outperforming Other Medical Stocks This Year?
by Zacks Equity Research
Is (TMO) Outperforming Other Medical Stocks This Year?
Bruker Rides on Nano and MALDI Launches Despite Margin Debacle
by Zacks Equity Research
Bruker (BRKR) has several Bruker NANO products that are being assembled and tested in Malaysia.
Abbott's Data From Interim Clinical Study of ID NOW Positive
by Zacks Equity Research
Abbott's (ABT) recent data from an interim clinical study on its ID NOW COVID-19 rapid test reflects the test's capacity to deliver effective, consistent and reliable performance.
Veeva Develops 2 Applications on Veeva Clinical Network (Revised)
by Zacks Equity Research
This should boost Veeva's (VEEV) portfolio of cloud-based offerings for the life sciences industry.
Bio-Rad (BIO) Hits a New 52-Week High: What's Driving It?
by Zacks Equity Research
Bio-Rad (BIO) is optimistic about maintaining robust testing portfolio along with strength in its Life Sciences business.
Booming Gene Editing Market to Pep Up These 5 Biotech Stocks
by Zacks Equity Research
Advancements in gene editing have boosted the biotech space, putting the spotlight on five stocks that can make the most.
NuVasive's (NUVA) MaXcess Retractor Study Results Positive
by Zacks Equity Research
NuVasive's (NUVA) MaXcess retractor's ability to perform lateral surgery in various approaches, including prone position, is validated by favorable study outcome.
3 Large-Cap MedTech Growth Stocks to Buy Amid the Pandemic
by Sriparna Ghosal
Let's take a look at three large-cap MedTech stocks that are currently flourishing on the back of a number of positive developments.
Ecolab Introduces New Automated Precision Dispensing System
by Zacks Equity Research
Ecolab's (ECL) newly launched Precision Dispensing System for Membranes can drive productivity and boost worker safety.
Pacific Biosciences Unveils Sequel IIe for HiFi Sequencing
by Zacks Equity Research
Pacific Biosciences' (PACB) recently-launched Sequel IIe System is powered by its SMRT technology.
Masimo Unveils New Wearable Wireless Continuous Thermometer
by Zacks Equity Research
Masimo's (MASI) wearable wireless continuous thermometer offers consumers hassle-free continuous body temperature measurements, thereby eliminating the need for manual measurements.
Medtronic Announces U.S. Launch of Adaptix, Expands Portfolio
by Zacks Equity Research
Medtronic (MDT) introduces fully-navigated titanium implant procedure in the United States with the launch of Adaptix Interbody System.
The Zacks Analyst Blog Highlights: Zoom Video, salesforce, Thermo Fisher, FedEx and Square
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Zoom Video, salesforce, Thermo Fisher, FedEx and Square
Jabil, Harley-Davidson, TMO, LHCG and NovoCure as Zacks Bull and Bear of the Day
by Zacks Equity Research
Jabil, Harley-Davidson, TMO, LHCG and NovoCure as Zacks Bull and Bear of the Day
Walgreens' Pharmacy International Arm Faces Coronavirus Woes
by Zacks Equity Research
Walgreens (WBA) expects the adverse impact of COVID-19 to continue in the fiscal fourth quarter.
Integra (IART) Preliminary Q3 Results Show Recovery in Sales
by Zacks Equity Research
Integra's (IART) sales improvement in the third quarter is broad-based across the major franchises as per preliminary statement.
Here's Why You Should Add NEOGEN (NEOG) to Your Portfolio Now
by Zacks Equity Research
Investors continue to be optimistic about NEOGEN (NEOG) on robust segmental and geographical growth.
FDA Amends Hologic's Aptima's EUA for Asymptomatic Testing
by Zacks Equity Research
The FDA's modified EUA for Hologic's (HOLX) Aptima SARS-CoV-2 assay includes testing of asymptomatic individuals and symptomatic pooling protocol to curb the spread of coronavirus.
Ecolab Disinfectant Gets EPA Nod for Use Against SARS-CoV-2
by Zacks Equity Research
Ecolab's (ECL) Peroxide Multi Surface Cleaner and Disinfectant is the first EPA-registered disinfectant proven to be effective at killing the SARS-CoV-2 virus.